Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127755301 | 12775530 | 1 | I | 201509 | 20160913 | 20160923 | 20160923 | EXP | GB-MHRA-ADR 23634312 | GB-TEVA-693693ACC | TEVA | 74.00 | YR | M | Y | 0.00000 | 20160923 | MD | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127755301 | 12775530 | 1 | PS | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | 15 MILLIGRAM DAILY; | U | 77255 | 15 | MG | QD | |||||||
| 127755301 | 12775530 | 2 | SS | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | 60 MILLIGRAM DAILY; | U | 77255 | 30 | MG | BID | |||||||
| 127755301 | 12775530 | 3 | C | PARACETAMOL | ACETAMINOPHEN | 1 | 0 | 500 | MG | ||||||||||
| 127755301 | 12775530 | 4 | C | ATORVASTATIN | ATORVASTATIN | 1 | 20 MILLIGRAM DAILY; | 0 | 20 | MG | QD | ||||||||
| 127755301 | 12775530 | 5 | C | HALOPERIDOL. | HALOPERIDOL | 1 | 0 | .5 | MG | ||||||||||
| 127755301 | 12775530 | 6 | C | NAPROXEN. | NAPROXEN | 1 | 500 MILLIGRAM DAILY; LONG TERM | 0 | 250 | MG | BID | ||||||||
| 127755301 | 12775530 | 7 | C | LOPRAZOLAM | LOPRAZOLAM | 1 | HALF A TABLET AT NIGHT. | 0 | 1 | MG | TABLET | ||||||||
| 127755301 | 12775530 | 8 | C | COLCHICINE. | COLCHICINE | 1 | 0 | 500 | UG | ||||||||||
| 127755301 | 12775530 | 9 | C | RANITIDINE. | RANITIDINE | 1 | 300 MILLIGRAM DAILY; | 0 | 150 | MG | BID | ||||||||
| 127755301 | 12775530 | 10 | C | ALLOPURINOL. | ALLOPURINOL | 1 | 300 MILLIGRAM DAILY; AT NIGHT. | 0 | 300 | MG | QD | ||||||||
| 127755301 | 12775530 | 11 | C | QUININE SULPHATE | QUININE SULFATE | 1 | 200 MILLIGRAM DAILY; AT NIGHT. | 0 | 200 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127755301 | 12775530 | 1 | Prophylaxis against gastrointestinal ulcer |
| 127755301 | 12775530 | 2 | Prophylaxis against gastrointestinal ulcer |
| 127755301 | 12775530 | 6 | Osteoarthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127755301 | 12775530 | OT |
| 127755301 | 12775530 | DS |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127755301 | 12775530 | Abnormal faeces | |
| 127755301 | 12775530 | Abnormal loss of weight | |
| 127755301 | 12775530 | Change of bowel habit | |
| 127755301 | 12775530 | Decreased appetite | |
| 127755301 | 12775530 | Diarrhoea | |
| 127755301 | 12775530 | Diverticulum | |
| 127755301 | 12775530 | Dizziness | |
| 127755301 | 12775530 | Dry mouth | |
| 127755301 | 12775530 | Fatigue | |
| 127755301 | 12775530 | Flatulence | |
| 127755301 | 12775530 | Gastritis | |
| 127755301 | 12775530 | Haemoglobin decreased | |
| 127755301 | 12775530 | Liver function test abnormal | |
| 127755301 | 12775530 | Nausea | |
| 127755301 | 12775530 | Pruritus | |
| 127755301 | 12775530 | Skin haemorrhage | |
| 127755301 | 12775530 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127755301 | 12775530 | 1 | 201508 | 201510 | 0 | |
| 127755301 | 12775530 | 2 | 201510 | 201607 | 0 |